loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 203281 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Glenmark Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GLENMARK PHARMS LTD (3)

    filter

    01 TABLET;ORAL (3)

    filter

    01 RX (3)

    filter

    01 OLMESARTAN MEDOXOMIL (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OLMESARTAN MEDOXOMIL

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    20MG
    2017-05-25
    203281
    OLMESARTAN MEDOXOM...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OLMESARTAN MEDOXOMIL

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    40MG
    2017-05-25
    203281
    OLMESARTAN MEDOXOM...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OLMESARTAN MEDOXOMIL

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    5MG
    2017-05-25
    203281
    OLMESARTAN MEDOXOM...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 203281

    Looking for FDA Orange Book APPLICATION 203281 3

    19

    Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is OLMESARTAN MEDOXOMIL, with a corresponding application number 203281.

    Regulatory Information RX

    With a dosage strength 20MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2017-05-25

    Therapeutic Equivalence (TE) Code AB

    18

    Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is OLMESARTAN MEDOXOMIL, with a corresponding application number 203281.

    Regulatory Information RX

    With a dosage strength 40MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2017-05-25

    Therapeutic Equivalence (TE) Code AB

    17

    Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is OLMESARTAN MEDOXOMIL, with a corresponding application number 203281.

    Regulatory Information RX

    With a dosage strength 5MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2017-05-25

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY